Efficacy and safety in patients with psoriasis treated continuously with adalimumab for approximately 3 years

被引：0
|
作者：
Gordon, Kenneth [1 ]
Sasso, Eric [2 ]
Gu, Yihua [2 ]
Poulin, Yves [3 ]
机构：
[1] NorthShore Univ HealthSystem, Evanston, IL USA
[2] Abbott, Abbott Pk, IL USA
[3] Ctr Dermatol Quebec Metropolitain, Quebec City, PQ, Canada
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2010年 / 62卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB140 / AB140
页数：1
相关论文
共 50 条
  • [41] Effectiveness and safety of switching from originator to biosimilar adalimumab in patients with psoriasis
    Nielsen, Valdemar Wendelboe
    Lund, Tamara Theresia
    Gniadecki, Robert
    Olsen, Rasmus Huan
    Nissen, Christoffer Valdemar
    Schwensen, Jakob Ferlov Baselius
    Thomsen, Simon Francis
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [42] EFFICACY OF ADALIMUMAB PLUS METHOTREXATE IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS
    Rokni, Ghasem Rahmatpour
    Goldust, Mohamad
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 10 - 10
  • [43] Long-term safety and efficacy of adalimumab from the phase 3 randomized placebo-controlled trial in patients with nail and skin psoriasis
    Crowley, Jeff
    Gisondi, Paolo
    Geng, Ziqian
    Servin, Ofelia Reyes
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB181 - AB181
  • [44] Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies
    Papp, Kim
    Okun, Martin
    Vender, Ronald
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 : S58 - S66
  • [45] Efficacy and safety of adalimumab, efalizumab and etanercept in the treatment of plaque-psoriasis 'in daily practice'
    Richter, L.
    Marker, M.
    Monshi, B.
    Mueksch, S. Richter
    Rappersberger, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 25 - 25
  • [46] LONG-TERM SAFETY AND EFFICACY OF ADALIMUMAB FROM THE PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL IN PATIENTS WITH NAIL AND SKIN PSORIASIS
    Crowley, Jeff
    Gisondi, Paolo
    Geng, Ziqian
    Servin, Ofelia Reyes
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 25 - 25
  • [47] Comment on "Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review"
    Asahina, Akihiko
    Nakagawa, Hidemi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (06) : E167 - E168
  • [48] EVALUATION OF EFFICACY AND SAFETY OF STEROIDS ADMINISTERED CONTINUOUSLY FOR 6 TO 10 YEARS
    COHEN, A
    ARCHIVES OF INTERAMERICAN RHEUMATOLOGY, 1962, 5 (04): : 507 - &
  • [49] Long-Term Efficacy and Safety of Adalimumab for up to 6 Years in Patients with Juvenile Idiopathic Arthritis
    Lovell, Daniel J.
    Ruperto, Nicolino
    Reiff, Andreas
    Jung, Lawrence K.
    Higgins, Gloria
    Kone-Paut, Isabelle
    Jones, Olcay Y.
    McIlraith, Melissa J.
    Andhivarothai, Nupun
    Kupper, Hartmut
    Giannini, Edward H.
    Peterson, Theresa
    Martini, Alberto
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S99 - S99
  • [50] EFFICACY AND SAFETY OF ADALIMUMAB IN PATIENTS WITH PERIPHERAL SPONDYLOARTHRITIS: RESULTS FROM A PHASE 3 STUDY
    Mease, P.
    Sieper, J.
    van den Bosch, F.
    Rahman, P.
    Obermeyer, K.
    Pangan, A. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 250 - 250
12345